Status:
COMPLETED
Analyses of Existing Framingham Data
Lead Sponsor:
National Eye Institute (NEI)
Conditions:
Eye Diseases
Eligibility:
All Genders
30-100 years
Brief Summary
Since 1948, the Framingham Study has examined a group of men and women every two years for the primary purpose of studying the incidence and prevalence of cardiovascular disease and its risk factors. ...
Detailed Description
We propose to continue to analyze existing Framingham Eye and Heart Study data to identify possible risk factors for various eye diseases. Originally begun in 1948 by the National Heart, Lung and Bloo...
Eligibility Criteria
Inclusion
- This study is of existing ocular data from the Framingham Eye Study. Since the participants have already been recruited, there are no further exclusions from the study.
Exclusion
Key Trial Info
Start Date :
June 25 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 25 2018
Estimated Enrollment :
6061 Patients enrolled
Trial Details
Trial ID
NCT00342810
Start Date
June 25 2003
End Date
April 25 2018
Last Update
December 17 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Eye Institute (NEI), 9000 Rockville Pike
Bethesda, Maryland, United States, 20892